Příspěvky

Zobrazují se příspěvky z 2013

60 Years of Data Reveal US Melanoma Epidemic

Survival 81% at 1 Year With MK-3475 in Melanoma

Obrázek
Survival 81% at 1 Year With MK-3475 in Melanoma

There is an overall survival rate of 81% at 1 year in patients with advanced and unresectable melanoma treated with the experimental immunotherapy MK-3475 (Merck), according to a Kaplan–Meier estimate from a phase 1 trial.
Related articlesInterim Data to Be Presented for MK-3475, Merck & Co., Inc.???s Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced MelanomaMerck Scores in Investigational Melanoma Study ResultsMerck updates MK-3475 data in MelanomaMerck's immunotherapy cancer treatment drug gets good patient response

Výběr - Journal of Clinical Oncology speciál 2013

Obrázek

Vitamin D level and Basal cell carcinoma, squamous cell carcinoma, and melanoma risk | DocGuide

Obrázek
Basal-cell carcinoma (Photo credit: Wikipedia)Vitamin D level and Basal cell carcinoma, squamous cell carcinoma, and melanoma risk | DocGuide

...  Pols et al. observed that baseline 25-hydroxyvitamin D (25OHD) levels above 75 nmol/L were associated with an increased incidence of basal cell carcinoma and melanoma, and a nonstatistically significant decreased incidence of squamous cell carcinoma...

Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab - Weber - 2013 - Cancer - Wiley Online Library

Obrázek